5:03 PM
 | 
Oct 25, 2013
 |  BC Extra  |  Company News

FDA approves GE imaging agent

FDA approved PET imaging agent Vizamyl [18F]-flutemetamol from the GE Healthcare unit of General Electric Co. (NYSE:GE) for use in estimating beta amyloid neuritic plaque density in adults with cognitive impairment who are being evaluated for Alzheimer's...

Read the full 173 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >